Cannabis Legalization – Clinical Implications & Major Papers

Oct 18, 2018
Author: 
David Gratzer

"It’s legal.

After decades of debate, Canada has legalized recreational marijuana, joining an exclusive club of nations with just one other member: Uruguay.

In the coming weeks, many details will be sorted out – some small (the regulation of edibles), some not so small (driving and use). But starting this week, we clinicians work in a different world.

What are the clinical implications of legalization? Will we see more use? How will people present to our EDs and clinics? What should we ask on a history? And how do we treat cannabinoid hyperemesis syndrome? (Spoiler alert: ginger stat.)

In the first selection, I highlight comments by CAMH’s Dr. Jonathan Bertram made in an interview with me. We discuss what every clinician should know about legalization.

And then with an eye on the journals, I pick a few essential articles on cannabis, drawing from The New England Journal, JAMA, and other major publications, considering topics from the adverse effects of marijuana to the implications for pain management."

Click here to read more of Dr. Gratzer's blog! 

Oct 9 5th Annual Continuing Professional & Practice Development (CPPD) Day
Departmental | 8:15am–3:45pm
Oct 31 Orientation Day for New Faculty
Departmental | 8:00am–5:00pm
Nov 21 Annual Department of Psychiatry Psychopharmacology Conference
Departmental | 8:00am–4:30pm
Nov 27 Promotions Primer
Departmental | 1:00pm–4:30pm